These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3596031)

  • 21. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposals for quality control methods of bacterial vaccines for immunostimulation. II. In vivo and in vitro stimulation of lymphocytes by BCG.
    Bruynzeel DP; Ettekoven H; Kreeftenberg JG
    Dev Biol Stand; 1977 Apr 13-15; 38():91-6. PubMed ID: 608553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative persistence capacity of BCG substrains in mouse spleen. Computerized statistical analysis. Multiple comparison.
    Lugosi L
    Can J Microbiol; 1992 Mar; 38(3):165-73. PubMed ID: 1393817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the quality control of BCG vaccine: laboratory examinations and postvaccination control in the field.
    Engibarov A; Chouchkova M; Koychev C
    Dev Biol Stand; 1986; 58 ( Pt A)():163-71. PubMed ID: 3596028
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
    Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of BCG vaccine lots for selection of replacement of the international BCG reference preparation.
    Ladefoged A; Bunch-Christensen K
    Dev Biol Stand; 1986; 58 ( Pt A)():65-71. PubMed ID: 3596051
    [No Abstract]   [Full Text] [Related]  

  • 27. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of pellicle and shake flask-grown BCG strains by quality control assays and protection studies.
    Fitzpatrick M; Ho MM; Clark S; Dagg B; Khatri B; Lanni F; Williams A; Brennan M; Laddy D; Walker B
    Tuberculosis (Edinb); 2019 Jan; 114():47-53. PubMed ID: 30711157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality control tests for vaccines in leprosy vaccine trial, Avadi.
    Sreevatsa ; Hari M; Gupte MD
    Indian J Lepr; 1998; 70(4):389-95. PubMed ID: 10189588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J; Levenbook I
    Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine.
    Ho MM; Markey K; Rigsby P; Jensen SE; Gairola S; Seki M; Castello-Branco LR; López-Vidal Y; Knezevic I; Corbel MJ
    Vaccine; 2008 Aug; 26(36):4754-7. PubMed ID: 18586063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the toxic effect on mice of a massive dose of French BCG after low, medium and high dose pretreatment of the French, Glaxo and Japan BCG strains.
    Lugosi L; Drinóczy M
    Dev Biol Stand; 1977; 34():189-91. PubMed ID: 838143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immuno BCG Pasteur F vaccine.
    Gheorghiu M; Chambon L; Serié C; Juvin-Calmette D
    Dev Biol Stand; 1977 Apr 13-15; 38():29-37. PubMed ID: 608512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilisation of BCG vaccines.
    Gheorghiu M; Lagranderie M; Balazuc AM
    Dev Biol Stand; 1996; 87():251-61. PubMed ID: 8854025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental study of the immunogenic and allergenic activity of different batches of Czechoslovak and Danish BCG vaccine in guinea pigs.
    Průchová J; Svandová E; Skrivanová R
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):469-80. PubMed ID: 4924334
    [No Abstract]   [Full Text] [Related]  

  • 37. Standardization of BCG multiple puncture 40 mg and BCG live (intravesical) Theracys/BCG therapeutic Immucyst.
    Csizer Z; Herbert A; Guest N; Sparkes J; Barreto L; Harjee N; Langlois S
    Dev Biol Stand; 1992; 77():223-7. PubMed ID: 1426666
    [No Abstract]   [Full Text] [Related]  

  • 38. Tuberculin sensitivity and morphological immune response in guinea pigs after application of minimal sensitizing dose of BCG vaccine, substrain Sofia SL222.
    Bachvarova M; Stefanova T; Nikolaeva S; Chouchkova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):1010-5. PubMed ID: 19393344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine.
    Gheorghiu M; Lagrange PH; Fillastre C
    J Biol Stand; 1988 Jan; 16(1):15-26. PubMed ID: 3350821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.